limonin has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, M; Fu, S; Gao, X; He, D; He, Y; Li, J; Li, Z; Liu, D; Liu, Y; Wang, H; Ye, B | 1 |
1 other study(ies) available for limonin and Parkinson Disease
| Article | Year |
|---|---|
Oral administration of Limonin (LM) exerts neuroprotective effects by inhibiting neuron autophagy and microglial activation in 6-OHDA-injected rats.
Topics: Administration, Oral; Aged; Animals; Autophagy; Humans; Inflammation; Limonins; Microglia; Middle Aged; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats | 2023 |